; (2) by redesignating subsection (d) as subsection (e); (3) by inserting after subsection (b) the following: (c) Antimalarial drugs (1) In general The Director shall consult with experts at the Centers for Disease Control and Prevention regarding recommendations for prescribing malaria prophylaxis, in order to provide the best standard of care within the context of the Peace Corps environment. (2) Certain training The Director shall ensure that each Peace Corps medical officer serving in a malaria-endemic country receives training in the recognition of the side effects of such medications. (3) Consultation The Director shall consult with the Assistant Secretary of Defense for Health Affairs regarding the policy of using mefloquine in the field as an antimalarial prophylactic. (d) Access to hygiene products Not later than 180 days after the date of the enactment of the Peace Corps Reauthorization Act of 2023 , the Director shall establish a comprehensive policy to ensure Peace Corps volunteers who require hygiene products are able to access such products. . 7. Codification of certain Executive orders relating to existing noncompetitive eligibility Federal hiring status for returning volunteers and extension of the period of such status The Peace Corps Act ( 22 U.S.C. 2501 et seq. ) is amended by inserting after section 5A the following: 5B. Codification of Executive orders relating to noncompetitive eligibility Federal hiring status for returning volunteers (a) In general Subject to subsection (b), Executive Order 11103 ( 22 U.S.C. 2504 note; relating to Providing for the Appointment of Former Peace Corps Volunteers to the Civilian Career Services), as amended by Executive Order 12107 (44 Fed. Reg. 1055